Generic Suboxone film on the horizon in the U.S.

Last month's news that a Delaware court is allowing Dr. Reddy's, a huge supplier of generic drugs based in India, to produce a generic version of buprenorphine‐naloxone film resulted in an immediate response from Indivior, which makes Suboxone (buprenorphine‐naloxone film) and has enjoyed a monopoly on it. Reckitt Benckiser (which Indivior spun off from in 2014) aroused outrage in the treatment field when generic versions of its Suboxone tablet came on the market and it responded by pulling the tablets, making only its patented film available. Now, Indivior will appeal the court ruling.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: News Source Type: research